While reporting financial results for the first quarter on Friday, biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) raised its adjusted earnings and net revenue guidance for the full-year 2026. For fiscal 2026, the company now projects adjusted earnings in the range of $9.19 to $9.69 per...
National HealthCare Corp. (NHC) released earnings for its first quarter that Increases, from last year The company's earnings totaled $35.86 million, or $2.27 per share. This compares with $32.21 million, or $2.07 per share, last year. Excluding items, National HealthCare Corp. reported adjusted...
ANI Pharmaceuticals, Inc. (ANIP) announced a profit for its first quarter that Increases, from last year The company's bottom line totaled $29.49 million, or $1.28 per share. This compares with $15.27 million, or $0.69 per share, last year. Excluding items, ANI Pharmaceuticals, Inc. reported adjusted...
Odyssey Therapeutics Inc. announced the pricing of its upsized initial public offering of 15.50 million shares of common stock at $18.00 per share. The company has also granted underwriters a 30-day option to purchase up to an additional 2.33 million shares at the same price, less underwriting discounts...
Artiva Biotherapeutics, Inc. (ARTV), a clinical-stage biotechnology company, on Friday announced the pricing of an underwritten offering of stock and pre-funded warrants. The offering consists of 23.87 million shares of stock priced at $11.52 per share and pre-funded warrants to purchase 2.17 million...
A total of 6.42 million doses of unapproved and counterfeit pharmaceuticals worth $15.5 million have been seized in a global crackdown. Operation Pangea XVIII, coordinated by Interpol across 90 countries during March 10 - 23, led to 269 arrests and the dismantling of 66 criminal groups involved in the illicit pharmaceutical trade. Law enforcement agencies worldwide launched 392 investigations an
Artiva Biotherapeutics, Inc. (ARTV) on Friday announced positive initial data from ongoing studies evaluating its cell therapy candidate AlloNK in combination with rituximab for patients with autoimmune diseases. The company's shares were up more than 10% in pre-market trading.
Tuesday, Johnson & Johnson (JNJ) announced Phase 2b data from two studies evaluating JNJ-4804 in patients with moderately to severely active ulcerative colitis or Crohn's disease. In the DUET-CD study, JNJ-4804a demonstrated higher clinical remission rates and endoscopic response rates than golimumab...
Johnson & Johnson (JNJ) on Tuesday announced positive results from the Phase 3 FUZION study evaluating TREMFYA in adults with active perianal fistulizing Crohn's disease. The study met its primary endpoint of combined fistula remission at Week 24, defined as complete closure of all external fistula...
Viridian Therapeutics, Inc. (VRDN) on Tuesday announced positive topline results from the Phase 3 REVEAL-2 study of elegrobart in patients with chronic thyroid eye disease, sending its shares up more than 25% in pre-market trading.
Eisai Co. Ltd (ESALY.PK) and Biogen Inc. (BIIB) on Friday said the U.S. Food and Drug Administration has extended by three months the review of LEQEMBI IQLIK as a starting dose for the treatment of early Alzheimer's disease. The new Prescription Drug User Fee Act (PDUFA) action date is August 24,...
The May FDA calendar appears relatively light. The upcoming regulatory milestones include a potential label expansion of argenx SE's VYVGART, and an additional indication for Daiichi Sankyo Company and AstraZeneca plc's cancer therapy Enhertu, among others.
March 31, 2026 15:49 ET In this week’s video, we’ll cover major biotech moves and breakthroughs - from Novartis and Merck’s blockbuster acquisitions to the first new Hunter syndrome therapy in two decades. We’ll also look at a promising alternative to daily insulin injections and the near-term catalyst for Q3 Bio, which has been hitting new 52-week highs.
a2 Milk Company Ltd. (ACOPF, A2M.AX), a dairy company, announced a recall of select infant milk formula, manufactured by Synlait Milk Limited and sold only in the United States, citing the presence of cereulide. The recall involves three batches of a2 Platinum USA label infant milk formula, comprising...
BioCardia Inc. (BCDA), a clinical-stage regenerative medicine company, on Friday announced alignment with the U.S. food and drug administration after a pre-submission meeting on the Helix transendocardial delivery catheter system. Helix was designed for the minimally invasive, targeted delivery of...
Researchers at Loma Linda University Health found that eating eggs may help lower the risk of Alzheimer's disease in adults aged 65 and older. The researchers used data from the Adventist Health Study-2, which includes health and diet information from more than 96,000 people. For this study, they...
New research led by psychologist Frank Infurna revealed that middle age has become harder in the United States compared to other rich countries. The study, which looked at survey data from 17 countries, found that Americans born in the 1960s and early 1970s feel lonelier and more depressed than older...
A new study published in Psychiatric Quarterly suggests that the emotional echoes of childhood- both good and bad- may play a far more powerful role in shaping mental health than previously understood.
Shares of Viemed Healthcare Inc. (VMD), a provider of home medical equipment and post-acute healthcare services in the United States, touched a new 52-week high of $10.10 during intraday trading yesterday. The company's sustained financial performance, combined with multiple growth engines, makes it a compelling long-term stock to watch.